M P M H Rutten-van Molken
Overview
Explore the profile of M P M H Rutten-van Molken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Schayck O, Slok A, Kotz D, van Breukelen G, Chavannes N, Rutten-van Molken M, et al.
Ned Tijdschr Geneeskd
. 2016 Nov;
160:D955.
PMID: 27805538
Objective: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD). Design: Cluster-randomised controlled...
2.
Kiel M, Roder E, Gerth van Wijk R, Rutten-van Molken M
Value Health
. 2016 May;
17(7):A597.
PMID: 27202055
No abstract available.
3.
Goossens L, Vasbinder E, van den Bemt P, Rutten-van Molken M
Value Health
. 2016 May;
17(7):A329.
PMID: 27200563
No abstract available.
4.
Kanters T, Redekop W, Kruijshaar M, van der Ploeg A, Rutten-van Molken M, Hakkaart L
Qual Life Res
. 2014 Oct;
24(4):837-44.
PMID: 25342117
Purpose: Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan...
5.
van Boven J, Tommelein E, Boussery K, Mehuys E, Vegter S, Brusselle G, et al.
J Pharm Belg
. 2014 Sep;
(3):15-6.
PMID: 25226758
No abstract available.
6.
Hoogendoorn M, Kappelhoff B, Overbeek J, Wouters E, Rutten-van Molken M
Neth J Med
. 2012 Oct;
70(8):357-64.
PMID: 23065983
Background: The aim of this study was to estimate the cost-effectiveness of tiotropium versus salmeterol to inform decision making within the Dutch healthcare setting. Methods: A previously published, validated COPD...
7.
Lemmens K, Nieboer A, Rutten-van Molken M, van Schayck C, Spreeuwenberg C, Asin J, et al.
BMJ Qual Saf
. 2011 Jan;
20(1):76-86.
PMID: 21228079
Objectives: To evaluate the implementation of three regional disease-management programmes on chronic obstructive pulmonary disease (COPD) based on bottlenecks experienced in professional practice. Methods: The authors performed a multisite comparison...
8.
van Wetering C, Hoogendoorn M, Mol S, Rutten-van Molken M, Schols A
Thorax
. 2009 Aug;
65(1):7-13.
PMID: 19703824
Background: The effectiveness of pulmonary rehabilitation in advanced COPD is well established, but few data are available in less advanced disease. Methods: In a 2 year randomised controlled trial, 199...
9.
Hoogendoorn M, van Wetering C, Schols A, Rutten-van Molken M
Eur Respir J
. 2009 Jul;
35(1):79-87.
PMID: 19574331
The study aimed to estimate the cost-effectiveness of interdisciplinary community-based chronic obstructive pulmonary disease (COPD) management in patients with COPD. We conducted a cost-effectiveness analysis alongside a 2-yr randomised controlled...
10.
Hoogendoorn M, Feenstra T, Rutten-van Molken M
Ned Tijdschr Geneeskd
. 2006 Jun;
150(22):1243-50.
PMID: 16796176
Objective: To determine the health-care utilisation and associated costs for asthma and chronic obstructive pulmonary disease (COPD) in the Netherlands for the year 2000 and to estimate future costs by...